These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6111043)

  • 21. Inhibitory serotonergic effects on rostral ventrolateral medullary neurons.
    Wang WH; Lovick TA
    Pflugers Arch; 1992 Nov; 422(2):93-7. PubMed ID: 1336851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that descending serotonergic systems protect spinal cord plasticity against the disruptive effect of uncontrollable stimulation.
    Crown ED; Grau JW
    Exp Neurol; 2005 Nov; 196(1):164-76. PubMed ID: 16139268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptic mechanisms acting on lumbar motoneurons during postural augmentation induced by serotonin injection into the rostral pontine reticular formation in decerebrate cats.
    Takakusaki K; Kohyama J; Matsuyama K; Mori S
    Exp Brain Res; 1993; 93(3):471-82. PubMed ID: 8519336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulatory and inhibitory effects of serotonergic hallucinogens on spinal mono- and polysynaptic reflex pathways in the rat.
    Yamazaki J; Ono H; Nagao T
    Neuropharmacology; 1992 Jul; 31(7):635-42. PubMed ID: 1407403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive increase of motor activity induced by 5-HTP in the rat below a complete secretion of the spinal cord.
    Bedard P; Barbeau H; Barbeau G; Filion M
    Brain Res; 1979 Jun; 169(2):393-7. PubMed ID: 312680
    [No Abstract]   [Full Text] [Related]  

  • 26. Serotonergic neurotransmission in the spinal cord and motor cortex of patients with motor neuron disease and controls: quantitative autoradiography for 5-HT1a and 5-HT2 receptors.
    Forrest V; Ince P; Leitch M; Marshall EF; Shaw PJ
    J Neurol Sci; 1996 Aug; 139 Suppl():83-90. PubMed ID: 8899664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of synapse density by 5-HT2A receptor agonist and antagonist in the spinal cord of chicken embryo.
    Niitsu Y; Hamada S; Hamaguchi K; Mikuni M; Okado N
    Neurosci Lett; 1995 Aug; 195(3):159-62. PubMed ID: 8584199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
    Jackson DA; White SR
    Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.
    Iverfeldt K; Peterson LL; Brodin E; Ogren SO; Bartfai T
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):1-6. PubMed ID: 2426604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-hydroxytryptophan-induced myoclonus in guinea pigs. A physiological and pharmacological investigations.
    Chadwick D; Hallett M; Jenner P; Marsden CD
    J Neurol Sci; 1978 Jan; 35(1):157-65. PubMed ID: 304885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection.
    Ung RV; Landry ES; Rouleau P; Lapointe NP; Rouillard C; Guertin PA
    Eur J Neurosci; 2008 Dec; 28(11):2231-42. PubMed ID: 19019202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of serotonin on crossed phrenic nerve activity in cervical spinal cord hemisected rats.
    Zhou SY; Goshgarian HG
    Exp Neurol; 1999 Dec; 160(2):446-53. PubMed ID: 10619561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous and NMDA evoked motor rhythms in the neonatal mouse spinal cord: an in vitro study with comparisons to in situ activity.
    Hernandez P; Elbert K; Droge MH
    Exp Brain Res; 1991; 85(1):66-74. PubMed ID: 1884765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic regulation of the spinal cord content of thyrotropin releasing hormone in the cerebellar ataxia mutant mouse.
    Endo S; Itoh M; Serizawa O
    J Neurol Sci; 1993 Sep; 118(2):194-201. PubMed ID: 8229069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenously released 5-hydroxytryptamine depresses the spinal monosynaptic reflex via 5-HT1D receptors.
    Honda M; Imaida K; Tanabe M; Ono H
    Eur J Pharmacol; 2004 Oct; 503(1-3):55-61. PubMed ID: 15496296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin refines the locomotor-related alternations in the in vitro neonatal rat spinal cord.
    Pearlstein E; Ben Mabrouk F; Pflieger JF; Vinay L
    Eur J Neurosci; 2005 Mar; 21(5):1338-46. PubMed ID: 15813943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denervation supersensitivity to 5-hydroxytryptamine in the rat spinal cord is not due to the absence of 5-hydroxytryptamine.
    Tremblay LE; Bédard PJ; Maheux R; Di Paolo T
    Brain Res; 1985 Mar; 330(1):174-7. PubMed ID: 3157425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT3 receptor-active drugs alter development of spinal serotonergic innervation: lack of effect of other serotonergic agents.
    Bell J; Zhang XN; Whitaker-Azmitia PM
    Brain Res; 1992 Feb; 571(2):293-7. PubMed ID: 1535269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Hydroxytryptamine1C/2 agonists in the thoracic spinal cord: cardiovascular effects and binding sites in the intermediolateral cell column.
    Helke CJ; Thor KB; Phillips ET
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1335-43. PubMed ID: 1762081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.